Results 311 to 320 of about 281,124 (345)
Some of the next articles are maybe not open access.
CTCs Could Shorten Drug Trials
Cancer Discovery, 2015Abstract In a phase III study, circulating tumor cells and blood levels of the enzyme lactate dehydrogenase predicted survival in patients with metastatic prostate cancer. Use of these biomarkers as surrogate predictors of survival could speed clinical trials of experimental therapies for prostate cancer.
openaire +2 more sources
IDrugs : the investigational drugs journal, 2005
Teijin and Chemo-Sero are codeveloping CTC-111 as a treatment for disseminated intravascular coagulation (DIC) due to protein C deficiency. The drug was launched for the treatment of protein C deficiency in Japan on January 31, 2001 and as of October 2001 was awaiting approval for the treatment of DIC, also in Japan [426762]. CTC-111 was evaluated in a
openaire +1 more source
Teijin and Chemo-Sero are codeveloping CTC-111 as a treatment for disseminated intravascular coagulation (DIC) due to protein C deficiency. The drug was launched for the treatment of protein C deficiency in Japan on January 31, 2001 and as of October 2001 was awaiting approval for the treatment of DIC, also in Japan [426762]. CTC-111 was evaluated in a
openaire +1 more source
Ultra-sensitive CTC-based liquid biopsy for pancreatic cancer enabled by large blood volume analysis
Molecular Cancer, 2023Nikolas H Stoecklein +2 more
exaly
Diagnostic yield of flexible sigmoidoscopy and CTC
Nature Reviews Gastroenterology and Hepatology, 2012Perry J Pickhardt
exaly